27. GLP-1 RA Added to Insulin Results in Durable Weight Loss and Glycemic Control in Type 2 Diabetes Patients: 2 Years Real-Life Follow-up Data (976-P)

Stefanie A. de Boer,Douwe J. Mulder,Joop D. Lefrandt,Klaas Hoogenberg

Nederlands Tijdschrift voor Diabetologie（2014）

Cited 0|Views0

No score

Abstract

Samenvatting Glucagon-like peptide-1 receptor agonists (GLP-1 RA) added to insulin in type 2 diabetes (T2DM) patients reduces HbA1c, total daily insulin dose (TDD), and body weight in short term studies (1-12 months). We evaluated these GLP-1 RA effects in a prospective real life cohort study of overweight T2DM patients on insulin after 6 weeks, 3, 6, 9, 12, 18 months and 2 years of treatment.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined